The Balfaxar market is witnessing steady growth over the forecast period, supported by increase in elderly patient surgeries, rising anticoagulant usage.
Read More
The BabyBIG market is witnessing steady growth over the forecast period, supported by improved surveillance of infant botulism, continued public health funding.
Read More
The Avonex market is witnessing steady growth over the forecast period, supported by expansion of ms patient population, demand for stable long-term therapies.
Read More
The Avastin (Bevacizumab) market is witnessing steady growth over the forecast period, supported by growth of bevacizumab biosimilars, expanding oncology patient pool.
Read More
The Autoplex market is witnessing steady growth over the forecast period, supported by growth in diagnosed inhibitor patients, expansion of specialty bleeding centers.
Read More
The Audenz market is witnessing steady growth over the forecast period, supported by rising risk of zoonotic infections, expansion of national stockpiles.
Read More
The Attenuvax market is witnessing steady growth over the forecast period, supported by renewed focus on measles prevention, expansion of vaccination coverage in emerging regions.
Read More
The Atryn market is witnessing steady growth over the forecast period, supported by increasing diagnosis of inherited thrombophilia, rising surgical intervention rates.
Read More
The Atgam market is witnessing steady growth over the forecast period, supported by increasing transplant procedure volumes, growing demand for targeted immunosuppression.
Read More
The Asparlas (calaspargase pegol) market is witnessing steady growth over the forecast period, supported by expansion of pediatric oncology programs, increasing global all diagnosis rates.
Read More